afatinib dimaleate

Afatinib Dimaleate received regulatory approval for use as a treatment for non-small cell lung cancer, although there is emerging evidence to support its use in other cancers such as breast cancer. Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma. Reference standards of Afatinib Dimaleate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Afatinib Dimaleate - API Standards 
    [catalogue_number] => PA 28 40000
    [category_ids] => ,89,79,80,70,82,78,
    [chemical_name] => 
    [weight] => 718.09
    [form] => C32H33ClFN5O11
    [cas] => 850140-73-7
    [pslug] => 850140-73-7-afatinib-dimaleate-api-pa2840000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)